Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.

Cingolani HE, Plastino JA, Escudero EM, Mangal B, Brown J, Pérez NG.

J Card Fail. 2006 Sep;12(7):491-8.

PMID:
16952781
2.

Oxipurinol: alloxanthine, Oxyprim, oxypurinol.

[No authors listed]

Drugs R D. 2004;5(3):171-5. Review.

PMID:
15139781
4.

The role of urate and xanthine oxidase inhibitors in cardiovascular disease.

George J, Struthers AD.

Cardiovasc Ther. 2008 Spring;26(1):59-64. doi: 10.1111/j.1527-3466.2007.00029.x. Review.

PMID:
18466421
5.

Uric acid in chronic heart failure.

Doehner W, Anker SD.

Semin Nephrol. 2005 Jan;25(1):61-6. Review.

PMID:
15660337
6.

Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.

Harzand A, Tamariz L, Hare JM.

Congest Heart Fail. 2012 May-Jun;18(3):179-82. doi: 10.1111/j.1751-7133.2011.00262.x. Epub 2011 Nov 9. Review.

7.

Progress towards the discovery of xanthine oxidase inhibitors.

Borges F, Fernandes E, Roleira F.

Curr Med Chem. 2002 Jan;9(2):195-217. Review.

PMID:
11860355
8.

Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure.

Bergamini C, Cicoira M, Rossi A, Vassanelli C.

Eur J Heart Fail. 2009 May;11(5):444-52. doi: 10.1093/eurjhf/hfp042. Epub 2009 Apr 4. Review.

9.

[The role of uric acid in heart failure].

Alcaíno H, Greig D, Castro P, Verdejo H, Mellado R, García L, Díaz-Araya G, Quiroga C, Chiong M, Lavandero S.

Rev Med Chil. 2011 Apr;139(4):505-15. doi: /S0034-98872011000400014. Epub 2011 Aug 25. Review. Spanish.

10.

Febuxostat, a nonpurine selective inhibitor of xanthine oxidase: a promising medical therapy for chronic heart failure?

Gao LG, Yao XP, Zhang L, Wen D, Luo F, Zhou XL, Hui RT.

Chin Med J (Engl). 2010 Sep;123(17):2471-4. Review. No abstract available.

PMID:
21034568

Supplemental Content

Support Center